Exercise study for prostate cancer patients pulled before it began

NCT ID NCT06282185

Terminated Symptom relief Sponsor: Canisius-Wilhelmina Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aimed to see if a 12-week supervised exercise program could improve quality of life and physical fitness in men with advanced prostate cancer receiving hormone therapy. Participants would have been randomly assigned to either the supervised program or usual care with exercise advice. However, the study was withdrawn before enrolling any participants, so no data were collected.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: supervised exercise program
What this could lead to: If it works, this could show that structured exercise helps men with advanced prostate cancer feel better and stay fitter during hormone therapy.
What could go wrong: The study was withdrawn before enrolling anyone, so no results are available. Exercise may not significantly improve quality of life or fitness for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic neoplasm metastatic prostate carcinoma Neoplasm Metastasis prostate cancer prostate neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTASIS PROSTATIC NEOPLASMS

Contacts and locations

Locations

Canisius Wilhelmina Ziekenhuis (CWZ)

Nijmegen, Gelderland, 6532SZ, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.